ZEGERID OTC OTC
Generic Name and Formulations:
Omeprazole 20mg, sodium bicarbonate 1100mg; per cap; contains 303mg Na+/cap.
Bayer Corp, Consumer Care Div.
Indications for ZEGERID OTC:
Frequent heartburn (≥2 days/week). Not intended for immediate relief of heartburn (may take 1–4 days for full effect).
Swallow whole. Take at least 1 hour before eating in the AM. ≥18yrs: one capsule daily for 14 days; may repeat 14-day course every 4 months.
<18yrs: not recommended.
Trouble or pain swallowing food. Vomiting with blood. Bloody or black stools.
Heartburn >3 months. Chest or shoulder pain with shortness of breath; sweating; pain spreading to arms, neck, or shoulders; or lightheadedness. Wheezing. Unexplained weight loss. Nausea/vomiting. Stomach pain. Sodium-restricted diets. Discontinue and reevaluate if condition continues or worsens after 14 days, require >1 course of treatment every 4 months; diarrhea, rash, or joint pain develops. Pregnancy. Nursing mothers.
Proton pump inhibitor + antacid.
May affect or be affected by blood-thinning agents (eg, warfarin, clopidogrel, cilostazol), antifungals, digoxin, diazepam, tacrolimus, mycophenolate mofetil, antiretrovirals, methotrexate.
Caps—14, 28, 42
Sign Up for Free e-newsletters
Infectious Disease Advisor Articles
- Antibiotic Use in Neonatal Settings in Need of Improvement
- Whole Genome Sequencing Use in Predicting TB Resistance
- Rapid Antimicrobial Susceptibility Testing on Urine Directly Accelerates Results
- Antibiotics May Be Beneficial in Children With Prolonged Wet Cough
- Emergency Department Overcrowding Associated With Delayed Antibiotics in Patients With Sepsis
- Success With DAA for Hepatitis C Prior to Stem Cell Transplant
- Shorter Antibiotic Course Noninferior for Gram-Negative Bacteremia
- Dolutegravir Plus Lamivudine Promising for HIV Maintenance Therapy
- Trial Results Affected by Heterogeneous CAP Inclusion Criteria
- Screening Blood Donations Mitigates Transfusion-Transmitted Babesiosis Risk